Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 59


Polypill-based therapy likely to reduce ethnic inequities in use of cardiovascular preventive medications: Findings from a pragmatic randomised controlled trial.

Selak V, Harwood M, Raina Elley C, Bullen C, Wadham A, Parag V, Rafter N, Arroll B, Bramley D, Crengle S.

Eur J Prev Cardiol. 2016 Feb 29. pii: 2047487316637196. [Epub ahead of print]


Persistent problems 1 year after mild traumatic brain injury: a longitudinal population study in New Zealand.

Theadom A, Parag V, Dowell T, McPherson K, Starkey N, Barker-Collo S, Jones K, Ameratunga S, Feigin VL; BIONIC Research Group.

Br J Gen Pract. 2016 Jan;66(642):e16-23. doi: 10.3399/bjgp16X683161.


Low-dose aspirin as an adjuvant treatment for venous leg ulceration: study protocol for a randomized controlled trial (Aspirin4VLU).

Jull A, Wadham A, Bullen C, Parag V, Kerse N, Waters J.

J Adv Nurs. 2016 Mar;72(3):669-79. doi: 10.1111/jan.12864. Epub 2015 Dec 28.


Improving Adherence to Secondary Stroke Prevention Strategies Through Motivational Interviewing: Randomized Controlled Trial.

Barker-Collo S, Krishnamurthi R, Witt E, Feigin V, Jones A, McPherson K, Starkey N, Parag V, Jiang Y, Barber PA, Rush E, Bennett D, Aroll B.

Stroke. 2015 Dec;46(12):3451-8. doi: 10.1161/STROKEAHA.115.011003. Epub 2015 Oct 27.


30-Year Trends in Stroke Rates and Outcome in Auckland, New Zealand (1981-2012): A Multi-Ethnic Population-Based Series of Studies.

Feigin VL, Krishnamurthi RV, Barker-Collo S, McPherson KM, Barber PA, Parag V, Arroll B, Bennett DA, Tobias M, Jones A, Witt E, Brown P, Abbott M, Bhattacharjee R, Rush E, Suh FM, Theadom A, Rathnasabapathy Y, Te Ao B, Parmar PG, Anderson C, Bonita R; ARCOS IV Group.

PLoS One. 2015 Aug 20;10(8):e0134609. doi: 10.1371/journal.pone.0134609. eCollection 2015.


E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial.

O'Brien B, Knight-West O, Walker N, Parag V, Bullen C.

Tob Induc Dis. 2015 Mar 24;13(1):5. doi: 10.1186/s12971-015-0030-2. eCollection 2015.


Cytisine versus nicotine for smoking cessation.

Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V, Parag V, Bassett B, Bullen C.

N Engl J Med. 2014 Dec 18;371(25):2353-62. doi: 10.1056/NEJMoa1407764.


Abrupt nicotine reduction as an endgame policy: a randomised trial.

Walker N, Fraser T, Howe C, Laugesen M, Truman P, Parag V, Glover M, Bullen C.

Tob Control. 2015 Dec;24(e4):e251-7. doi: 10.1136/tobaccocontrol-2014-051801. Epub 2014 Nov 14.


Effect of a family-centered, secondhand smoke intervention to reduce respiratory illness in indigenous infants in Australia and New Zealand: a randomized controlled trial.

Walker N, Johnston V, Glover M, Bullen C, Trenholme A, Chang A, Morris P, Segan C, Brown N, Fenton D, Hawthorne E, Borland R, Parag V, Von Blaramberg T, Westphal D, Thomas D.

Nicotine Tob Res. 2015 Jan;17(1):48-57. doi: 10.1093/ntr/ntu128. Epub 2014 Aug 25.


Pharmacy-based screening for atrial fibrillation in high-risk Maori and Pacific populations.

Walker N, Doughty R, Parag V, Harrison J, Bennett M, Freedman B.

N Z Med J. 2014 Jul 18;127(1398):128-31. No abstract available.


Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.

Selak V, Elley CR, Bullen C, Crengle S, Wadham A, Rafter N, Parag V, Harwood M, Doughty RN, Arroll B, Milne RJ, Bramley D, Bryant L, Jackson R, Rodgers A.

BMJ. 2014 May 27;348:g3318. doi: 10.1136/bmj.g3318.


Electronic cigarettes and smoking cessation: a quandary? - Authors' reply.

Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N.

Lancet. 2014 Feb 1;383(9915):408-9. doi: 10.1016/S0140-6736(14)60146-X. No abstract available.


Methodology of a population-based stroke and TIA incidence and outcomes study: the Auckland Regional Community Stroke Study (ARCOS IV) 2011-2012.

Krishnamurthi R, Jones A, Barber PA, Barker-Collo S, McPherson K, Bennett D, Rush E, Suh F, Starkey N, Theadom A, Parag V, Rathnasabapathy Y, Feigin VL; ARCOS IV Programme Group.

Int J Stroke. 2014 Jan;9(1):140-7. doi: 10.1111/ijs.12108. Epub 2013 Oct 27.


Reducing recurrent stroke: methodology of the motivational interviewing in stroke (MIST) randomized clinical trial.

Krishnamurthi R, Witt E, Barker-Collo S, McPherson K, Davis-Martin K, Bennett D, Rush E, Suh F, Starkey N, Parag V, Rathnasabapathy Y, Jones A, Brown P, Te Ao B, Feigin VL; ARCOS IV Programme Group.

Int J Stroke. 2014 Jan;9(1):133-9. doi: 10.1111/ijs.12107. Epub 2013 Oct 27.


Electronic cigarettes for smoking cessation: a randomised controlled trial.

Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N.

Lancet. 2013 Nov 16;382(9905):1629-37. doi: 10.1016/S0140-6736(13)61842-5. Epub 2013 Sep 9.


Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation.

Bullen C, Williman J, Howe C, Laugesen M, McRobbie H, Parag V, Walker N.

BMC Public Health. 2013 Mar 8;13:210. doi: 10.1186/1471-2458-13-210.


Pentoxifylline for treating venous leg ulcers.

Jull AB, Arroll B, Parag V, Waters J.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD001733. doi: 10.1002/14651858.CD001733.pub3. Review.


Incidence of traumatic brain injury in New Zealand: a population-based study.

Feigin VL, Theadom A, Barker-Collo S, Starkey NJ, McPherson K, Kahan M, Dowell A, Brown P, Parag V, Kydd R, Jones K, Jones A, Ameratunga S; BIONIC Study Group.

Lancet Neurol. 2013 Jan;12(1):53-64. doi: 10.1016/S1474-4422(12)70262-4. Epub 2012 Nov 22.


Prevalence and predictors of 6-month fatigue in patients with ischemic stroke: a population-based stroke incidence study in Auckland, New Zealand, 2002-2003.

Feigin VL, Barker-Collo S, Parag V, Hackett ML, Kerse N, Barber PA, Theadom A, Krishnamurthi R; Auckland Regional Community Stroke Study Group.

Stroke. 2012 Oct;43(10):2604-9. Epub 2012 Jul 31.


The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial.

Walker N, Howe C, Bullen C, Grigg M, Glover M, McRobbie H, Laugesen M, Parag V, Whittaker R.

Addiction. 2012 Oct;107(10):1857-67. doi: 10.1111/j.1360-0443.2012.03906.x. Epub 2012 May 17.

Items per page

Supplemental Content

Write to the Help Desk